Showing results (211-220 of 279) with videos related to
Sort By:
Pageof 28
Oncotarget|June 9, 2016
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptorDaniel J Coleman, Kathryn Van Hook, Carly J King, et al.Cancers|July 24, 2021
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical PracticeLincoln D Nadauld, Charles H McDonnell, Tomasz M Beer, et al.Journal of Medical Internet Research|December 31, 2020
Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot TrialJune M Chan, Erin L Van Blarigan, Crystal S Langlais, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) StudyGhada N Farhat, Emanuela Taioli, Jane A Cauley, et al.Proceedings of the National Academy of Sciences of the United States of America|February 18, 2026
Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancerMatthew D Galsky, Sudeh Izadmehr, Menggang Yu, et al.Journal of Translational Medicine|December 16, 2018
Implementing a comprehensive translational oncology platform: from molecular testing to actionabilityZahi I Mitri, Swapnil Parmar, Brett Johnson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancerMary-Ellen Taplin, Meredith M Regan, Yoo-Joung Ko, et al.JMIR Research Protocols|November 17, 2018
Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled TrialKerri M Winters-Stone, Stacey A Kenfield, Erin L Van Blarigan, et al.European Urology|March 24, 2016
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerChristopher P Evans, Celestia S Higano, Thomas Keane, et al.Lancet (London, England)|April 20, 2010
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 studyHoward I Scher, Tomasz M Beer, Celestia S Higano, et al.Pageof 28